Patel Dinesh V PH D's Form 4 filing
Protagonist Therapeutics, Inc (PTGX) · filed Jul 23, 2025
- Accession no.
- 0001104659-25-070104
- Filed
- Jul 23, 2025
- Trade date
- Jul 21-23, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.88M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patel Dinesh V PH DCIK 0001120477 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 21, 2025 | Common Stock | AGrant or awardAcquired | +25,000 | $0.00 | $0 | 583,462 | Direct | |
| Jul 21, 2025 | Common Stock | SSaleDisposed | −12,859 | $54.86 | −$705,444.74 | 570,603 | Direct | |
| Jul 22, 2025 | Common Stock | SSaleDisposed | −22,065 | $55.05 | −$1,214,678.25 | 548,538 | Direct | |
| Jul 23, 2025 | Common Stock | SSaleDisposed | −17,520 | $54.79 | −$959,920.8 | 531,018 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.